Merck Announces Clinical Holds on Studies Evaluating Islatravir for the Treatment and Prevention of HIV-1 Infection
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Oil rally pressures S&P, Nasdaq; Microsoft, Salesforce buoy Dow
- Oil prices rise 2% as attacks on Saudi Arabia overshadow Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
| Merck & Co. (NYSE: MRK) | Delayed: 145.22 -0.38 (0.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $145.60 | 52 Week High | $65.46 | |||
| Open | $145.75 | 52 Week Low | $47.97 | |||
| Day High | $146.36 | P/E | 98.79 | |||
| Day Low | $144.64 | EPS | $1.47 | |||
| Volume | 3,313,812 | |||||
